# A Phase 1 Study of AV-380 in Healthy Subjects

> **NCT04815551** · PHASE1 · COMPLETED · sponsor: **AVEO Pharmaceuticals, Inc.** · enrollment: 51 (actual)

## Conditions studied

- Cachexia

## Interventions

- **DRUG:** AV-380
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04815551
- **Lead sponsor:** AVEO Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-22
- **Primary completion:** 2022-01-14
- **Final completion:** 2022-01-14
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2023-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04815551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04815551, "A Phase 1 Study of AV-380 in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04815551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*